Smitha Jagadish

Smitha Jagadish is currently the Vice President and Head of Rare Diseases and New Modalities at BIAL. Prior to this role, Smitha held positions at Grünenthal Group, Sanofi Genzyme, Whitehead Institute, University of California San Francisco, and Columbia University Medical Center. Smitha's research has focused on various aspects of neuroscience, including amyloid deposition in Alzheimer's disease, reward learning, motor performance, neural circuits, and neurodegenerative diseases. Smitha holds a Ph.D. in Neuroscience from Columbia University.